Sorry, no posts found.
- CRA WEBINAR: LEGISLATIVE UPDATE 2023
- CRA Partner: Cleveland Clinic Biologic Therapies Summit X and Vasculitis 2023
- 2023 CRA 19th Annual Meeting at the Carl Pearson Symposium: April 28-29, 2023
- 2022 CRA Honorary Luncheon celebrating Dr. Michael Stevens
- CRA 18th Annual Meeting Registration NOW OPEN! Reserve your seat today!
- CRA Diamond Member News: Abbvie Ankylosing Spondylitis resource
- CRA Diamond Member News: AS: Lessons from HCP Journeys
- CRA Diamond Member News: Pfizer Medical Portal Open
- Manuscript with ORAL Surveillance Data Available in the New England Journal of Medicine January 27 Issue
- FDA Approval of Xeljanz (tofacitinib) for Ankylosing Spondylitis
- Abbvie receives FDA approval for Rinvoq to treat active Psoriatic Arthritis
- U.S. FDA Approves Cyltezo® (adalimumab-adbm) as First Interchangeable Biosimilar with Humira®
- CRA President, Dr. Samy Metyas featured in Capitol Weekly Op-Ed
- Anthem Clarifies Specialty Pharmacy Mandate
- CRA Issues Letters to California Business Advocacy Organizations Warning Them of Consequences of Anthem Blue Cross Mandate